Verisiguat etkileşimleri

PDE-5 Inhibitors: Concomitant use is not recommended. (Verisiguat etiketi, İlaç etkileşimleri)

PDE-5 Inhibitors: Concomitant use is not recommended. (Verisiguat etiketi, İlaç etkileşimleri)

PDE-5 Inhibitors: Concomitant use is not recommended. (Verisiguat etiketi, İlaç etkileşimleri)

PDE-5 Inhibitors: Concomitant use is not recommended. (Verisiguat etiketi, İlaç etkileşimleri)

Hypotension Adenosine injection is a potent peripheral vasodilator and can induce significant hypotension. (Adenozin etiketi, Uyarılar ve önlemler)

Nonetheless, caution, as with any other peripheral vasodilator, should be exercised when administering amlodipine, particularly in patients with severe aortic stenosis. (Amlodipin ve valsartan etiketi, Uyarılar ve önlemler)

• Co-administration with Other Vasodilators or Negative Chronotropic Agents : Use with caution due to additive pharmacodynamic effects. (Deksmedetomidin etiketi, Uyarılar ve önlemler)

Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (Epoprostenol etiketi, İlaç etkileşimleri)

Drug Interactions The vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators. (İzosorbid dinitrat etiketi, İlaç etkileşimleri)

The vasodilating effects of isosorbide mononitrate may be additive with those of other vasodilators. (İzosorbid mononitrat etiketi, İlaç etkileşimleri)

Valvular Stenosis There is concern, on theoretical grounds, that patients with aortic stenosis might be at particular risk of decreased coronary perfusion when treated with vasodilators because they do not develop as much afterload reduction as others. (Kaptopril etiketi, Önlemler)

Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (Nifedipin etiketi, İlaç etkileşimleri)

Antihypertensive Agents Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure. (Verapamil etiketi, İlaç etkileşimleri)

Drugs antagonizing pressor effects of epinephrine α-blockers, such as phentolamine Vasodilators, such as nitrates Diuretics Antihypertensives Ergot alkaloids Drugs potentiating pressor effects of epinephrine • Sympathomimetics • β-blockers, such as propranolol • Tricyclic anti-depressants • Monoamine oxidase (MAO) inhibitors • Catechol-O-methyl transferase (COMT)… (Adrenalin etiketi, İlaç etkileşimleri)

Phosphodiesterase-5 (PDE5) Inhibitors: PDE5-inhibitors are also vasodilators. (Alfuzosin etiketi, Uyarılar ve önlemler)

Alpha-adrenergic antagonists and PDE-5 inhibitors are both vasodilators that can lower blood pressure. (Dutasterid ve tamsulosin etiketi, Uyarılar ve önlemler)

Post injury arterial injection of vasodilators and/or arterial infusion of parenteral fluids are generally regarded to be of no value in altering outcome. (Metoheksital etiketi, Uyarılar)

Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (Silodosin etiketi, Uyarılar ve önlemler)

Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (Tamsulosin etiketi, Uyarılar ve önlemler)